Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

The Oncology Institute Inc WT (TOIIW)

The Oncology Institute Inc WT (TOIIW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 393,412 K
  • Annual Income, $ -64,663 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield (Fwd) N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector N/A
  • INDUSTRY GROUPING N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0350 +57.14%
on 03/03/26
0.1275 -56.86%
on 02/10/26
-0.0650 (-54.17%)
since 02/03/26
3-Month
0.0350 +57.14%
on 03/03/26
0.2000 -72.50%
on 01/26/26
-0.0849 (-60.69%)
since 12/04/25
52-Week
0.0175 +214.29%
on 04/14/25
0.2725 -79.82%
on 10/28/25
+0.0270 (+96.43%)
since 03/04/25

Most Recent Stories

More News
The Oncology Institute Announces Fourth Quarter and Full Year 2025 Earnings Release Date and Conference Call

CERRITOS, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (“TOI”) (NASDAQ: TOI)  a pioneer in value-based community oncology care, today announced that the company will release...

TOIIW : 0.0550 (+17.02%)
TOI : 2.80 (-1.75%)
The Oncology Institute to Participate in Multiple Healthcare Investor Conferences in March

CERRITOS, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), a pioneer in value-based community oncology care, today announced that members of its executive leadership...

TOIIW : 0.0550 (+17.02%)
TOI : 2.80 (-1.75%)
The Oncology Institute Appoints Kim Tzoumakas to Board of Directors

CERRITOS, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (“TOI”) (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced the appointment...

TOIIW : 0.0550 (+17.02%)
TOI : 2.80 (-1.75%)
The Oncology Institute Reaffirms 2025 Guidance and Provides Preliminary 2026 Outlook

CERRITOS, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based oncology groups in the United States, today...

TOIIW : 0.0550 (+17.02%)
TOI : 2.80 (-1.75%)
The Oncology Institute Announces Leadership Promotions

Rakesh Panda appointed Chief Information Officer Nolan Mariano appointed Chief People Officer CERRITOS, Calif., Jan. 09, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI)...

TOIIW : 0.0550 (+17.02%)
TOI : 2.80 (-1.75%)
The Oncology Institute Announces Addition of Board Member Mark Stolper

CERRITOS, Calif., Jan. 05, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (“TOI”) (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced that Mark...

TOIIW : 0.0550 (+17.02%)
RDNT : 66.52 (-6.74%)
TOI : 2.80 (-1.75%)
The Oncology Institute Announces Resignation of Board Member Gabe Ling

CERRITOS, Calif., Dec. 01, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (“TOI”) (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced that Gabe...

TOIIW : 0.0550 (+17.02%)
TOI : 2.80 (-1.75%)
The Oncology Institute Reports Third Quarter 2025 Financial Results and Increases Full Year 2025 Guidance

CERRITOS, Calif., Nov. 13, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based community oncology groups in the United...

TOIIW : 0.0550 (+17.02%)
TOI : 2.80 (-1.75%)
Ascertain and The Oncology Institute Co-Develop ‘Touchless’ AI Automation for Oncology Administration

CERRITOS, Calif. and NEW YORK, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Ascertain , a healthcare technology company pioneering agentic AI to automate administrative workflows, and The Oncology Institute,...

TOIIW : 0.0550 (+17.02%)
TOI : 2.80 (-1.75%)
The Oncology Institute Announces Third Quarter 2025 Earnings Release Date and Conference Call

CERRITOS, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (“TOI”) (NASDAQ: TOI),  a pioneer in value-based community oncology care, today announced that the company will release...

TOIIW : 0.0550 (+17.02%)
TOI : 2.80 (-1.75%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Strengthening short term outlook on maintaining the current direction.

See More Share

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar